Adiponectin induces interleukin-6 production and activates STAT3 in adult mouse cardiac fibroblasts

Biology of the Cell

Volumn 101, Issue 5, 2009, Pages 263-272

  Liao, Wenqiang ^a   Yu, Changan ^a   Wen, Jianyan ^a   Jia, William ^b   Li, Geng ^a   Ke, Yuannan ^a   Zhao, Shumin ^c   Campell, William ^c  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Pegasus Pharmaceuticals Group Inc   (Canada)

Author keywords

Adiponectin; Cardiac fibroblasts; Interleukin 6; Signal transducer and activator of transcription 3 (STAT3)

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; GLYCOPROTEIN GP 130; INTERLEUKIN 6; JANUS KINASE; MESSENGER RNA; NEUTRALIZING ANTIBODY; SMALL INTERFERING RNA; STAT3 PROTEIN; TYROSINE DERIVATIVE; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, MOUSE; ADIPONECTIN RECEPTOR 2, MOUSE; JANUS KINASE 2;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; FIBROBLAST; GENETIC TRANSFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; HEART MUSCLE CELL; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION;

ADIPONECTIN; ANIMALS; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; INTERLEUKIN-6; JANUS KINASE 2; MICE; MICE, INBRED BALB C; MYOCYTES, CARDIAC; PHOSPHORYLATION; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 64749092804     PISSN: 02484900     EISSN: 1768322X     Source Type: Journal    
DOI: 10.1042/BC20080117     Document Type: Article

References (45)

1. Abel, E.D., Litwin, S.E. and Sweeney, G. (2008) Cardiac remodeling in obesity. Physiol. Rev. 88, 389-419
2. Ahima, R.S. and Osei, S.Y. (2008) Adipokines in obesity. Front. Horm. Res. 36, 182-197
3. Barnett, A.H. (2008) The importance of treating cardiometabolic risk factors in patients with type2 diabetes. Diab. Vasc. Dis. Res. 5, 9-14
4. Boyle, K. and Robb, L. (2008) The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development. J. Reprod. Immunol. 77, 1-6
5. Chen, Z. and Han, Z.C. (2008) STAT3: a critical transcription activator in angiogenesis. Med. Res. Rev. 28, 185-200
6. Croker, B.A., Krebs, D.L., Zhang, J.G., Wormald, S., Willson, T.A., Stanley, E.G., Robb, L., Greenhalgh, C.J., Forster, I., Clausen, B.E. et al. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540-545
7. Dalpke, A., Heeg, K., Bartz, H. and Baetz, A. (2008) Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology 213, 225-235
8. Ding, G., Qin, Q., He, N., Francis-David, S.C., Hou, J., Liu, J., Ricks, E. and Yang, Q. (2007) Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor γ. J. Mol. Cell. Cardiol. 43, 73-84
9. Fischer, P. and Hilfiker-Kleiner, D. (2007) Survival pathways in hypertrophy and heart failure: the gp130-STAT axis. Basic Res. Cardiol. 102, 279-297
10. Fischer, P. and Hilfiker-Kleiner, D. (2008) Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects. Br. J. Pharmacol. 153, S414-S427
11. Fredj, S., Bescond, J., Louault, C., Delwail, A., Lecron, J.C. and Potreau, D. (2005) Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation. J. Cell. Physiol. 204, 428-436
12. Fujioka, D., Kawabata, K., Saito, Y., Kobayashi, T., Nakamura, T., Kodama, Y., Takano, H., Obata, J.E., Kitta, Y., Umetani, K. and Kugiyama, K. (2006) Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am. J. Physiol. Heart Circ. Physiol. 290, H2409-H2416
13. Fujita, K., Maeda, N., Sonoda, M., Ohashi, K., Hibuse, T., Nishizawa, H., Nishida, M., Hiuge, A., Kurata, A., Kihara, S. et al. (2008) Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-α. Arterioscler. Thromb. Vasc. Biol. 28, 863-870
14. Gonon, A.T., Widegren, U., Bulhak, A., Salehzadeh, F., Persson, J., Sjöquist, P.O. and Pernow, J. (2008) Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovasc. Res. 78, 116-122
15. Greenhalgh, C.J., Miller, M.E., Hilton, D.J. and Lund, P.K. (2002) Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease. Gastroenterology 123, 2064-2081
16. Hattori, Y., Hattori, S., Akimoto, K., Nishikimi, T., Suzuki, K., Matsuoka, H. and Kasai, K. (2007) Globular adiponectin activates nuclear factor-?B and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts. Diabetes 56, 804-808
17. Hattori, Y., Nakano, Y., Hattori, S., Tomizawa, A., Inukai, K. and Kasai, K. (2008) High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-κB activation in vascular endothelial cells. FEBS Lett. 582, 1719-1724
18. Hilfiker-Kleiner, D., Limbourg, A. and Drexler, H. (2005) STAT3-mediated activation of myocardial capillary growth. Trends Cardiovasc. Med. 15, 152-157
19. Isomoto, H., Mott, J.L., Kobayashi, S., Werneburg, N.W., Bronk, S.F., Haan, S. and Gores, G.J. (2007) Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. Gastroenterology 132, 384-396
20. Jost, M., Huggett, T.M., Kari, C., Boise, L.H. and Rodeck, U. (2001) Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway. J. Biol. Chem. 276, 6320-6326
21. Kadowaki, T. and Yamauchi, T. (2005) Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439-451
22. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K. and Tobe, K. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 1784-1792
23. Kurdi, M. and Booz, G.W. (2007) Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling. J. Cardiovasc. Pharmacol. 50, 126-141
24. Laubner, K., Kieffer, T.J., Lam, N.T., Niu, X., Jakob, F. and Seufert, J. (2005) Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic β-cells. Diabetes 54, 3410-3417
25. Lee, A.A., Dillmann, W.H., McCulloch, A.D. and Villarreal, F.J. (1995) Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts. J. Mol. Cell. Cardiol. 27, 2347-2357
26. Martha, L., Michael, P. and Rice, G.E. (2005) Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-κB, peroxisomal proliferator-activated receptor-γ and extracellularly regulated kinase 1/2. Endocrinology 146, 3334-3342
27. Murray, P.J. (2007) The JAK-STAT signaling pathway: input and output integration. J. Immunol. 178, 2623-2629
28. Ozawa, Y., Nakao, K., Kurihara, T., Shimazaki, T., Shimmura, S., Ishida, S., Yoshimura, A., Tsubota, K. and Okano, H. (2008) Roles of STAT3/SOCS3 pathway in regulation of the visual function and ubiquitin proteasome-dependent degradation of rhodopsin during retinal inflammation. J. Biol. Chem. 283, 24561-24570
29. Patrick, F., Ute, L., Radoslaw, M.S., Jochen, S., Claudia, N., Sonja, L., Serge, H., Iris, B., Akihiko, Y., James, A.J., Gerhard, M.U., Peter, C.H. and Fred, S. (2004) The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Biochem. J. 378, 449-460
30. Shapiro, L. and Scherer, P.E. (1998) The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8, 335-340
31. Shibata, R., Ouchi, N., Ito, M., Kihara, S., Shiojima, I., Pimentel, D.R., Kumada, M., Sato, K., Schiekofer, S., Ohashi, K. et al. (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 10, 1384-1389
32. Shibata, R., Sato, K., Pimentel, D.R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N. and Walsh, K. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11, 1096-1103
33. Shibata, R., Izumiya, Y., Sato, K., Papanicolaou, K., Kihara, S., Colucci, W.S., Sam, F., Ouchi, N. and Walsh, K. (2007) Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J. Mol. Cell. Cardiol. 42, 1065-1074
34. Skurk, C., Wittchen, F., Suckau, L., Witt, H., Noutsias, M., Fechner, H., Schultheiss, H.P. and Poller, W. (2008) Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur. Heart J. 29, 1168-1180
35. Steffens, S. and Mach, F. (2008) Adiponectin and adaptive immunity: linking the bridge from obesity to atherogenesis. Circ. Res. 102, 140-142
36. Tian, L., Luo, N., Klein, R.L., Chung, B.H., Garvey, W.T. and Fu, Y. (2008) Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis, doi:10.1016/j.atherosclerosis.2008.04.011
37. Wang, Y., Lam, K.S., Yau, M.H. and Xu, A. (2008) Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem. J. 409, 623-633
38. Wang, Z.V. and Scherer, P.E. (2008) Adiponectin, cardiovascular function, and hypertension. Hypertension 51, 8-14
39. Weber, K.T. and Brilla, C.G. (1991) Pathological hypertrophy and cardiac interstitium fibrosis and renin-angiotensin-aldosterone system. Circulation 83, 1849-1865
40. Wormald, S., Zhang, J.G., Krebs, D.L., Mielke, L.A., Silver, J., Alexander, W.S., Speed, T.P., Nicola, N.A. and Hilton, D.J. (2006) The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J. Biol. Chem. 281, 11135-11143
41. Yadav, A., Kalita, A., Dhillon, S. and Banerjee, K. (2005) JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3. J. Biol. Chem. 280, 31830-31840
42. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M. et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769
43. Yamauchi-Takihara, K. (2002) Gp130-mediated pathway and left ventricular remodeling. J. Card. Fail. 8, S374-S378
44. Yin, F., Wang, Y.Y., Du, J.H., Li, C., Lu, Z.Z., Han, C. and Zhang, Y.Y. (2006) Noncanonical cAMP pathway and p38 MAPK mediate β2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts. J. Mol. Cell. Cardiol. 40, 384-393
45. Yoshimura, A., Naka, T. and Kubo, M. (2007) SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465